Ensign Peak Advisors’s Myriad Genetics MYGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $168K | Hold |
31,606
| – | – | ﹤0.01% | 1684 |
|
|
2025
Q1 | $280K | Hold |
31,606
| – | – | ﹤0.01% | 1648 |
|
|
2024
Q4 | $433K | Hold |
31,606
| – | – | ﹤0.01% | 1632 |
|
|
2024
Q3 | $866K | Hold |
31,606
| – | – | ﹤0.01% | 1406 |
|
|
2024
Q2 | $773K | Hold |
31,606
| – | – | ﹤0.01% | 1443 |
|
|
2024
Q1 | $674K | Sell |
31,606
-1,594
| -5% | -$34K | ﹤0.01% | 1544 |
|
|
2023
Q4 | $635K | Buy |
33,200
+16,850
| +103% | +$323K | ﹤0.01% | 1603 |
|
|
2023
Q3 | $262K | Hold |
16,350
| – | – | ﹤0.01% | 1708 |
|
|
2023
Q2 | $379K | Buy |
+16,350
| New | +$379K | ﹤0.01% | 1689 |
|
|
2022
Q4 | – | Sell |
-28,188
| Closed | -$538K | – | 2068 |
|
|
2022
Q3 | $538K | Hold |
28,188
| – | – | ﹤0.01% | 1416 |
|
|
2022
Q2 | $512K | Hold |
28,188
| – | – | ﹤0.01% | 1448 |
|
|
2022
Q1 | $710K | Hold |
28,188
| – | – | ﹤0.01% | 1394 |
|
|
2021
Q4 | $778K | Sell |
28,188
-34,610
| -55% | -$955K | ﹤0.01% | 1406 |
|
|
2021
Q3 | $2.03M | Hold |
62,798
| – | – | ﹤0.01% | 1115 |
|
|
2021
Q2 | $1.92M | Hold |
62,798
| – | – | ﹤0.01% | 1154 |
|
|
2021
Q1 | $1.91M | Hold |
62,798
| – | – | ﹤0.01% | 1136 |
|
|
2020
Q4 | $1.24M | Hold |
62,798
| – | – | ﹤0.01% | 1307 |
|
|
2020
Q3 | $819K | Hold |
62,798
| – | – | ﹤0.01% | 1394 |
|
|
2020
Q2 | $712K | Hold |
62,798
| – | – | ﹤0.01% | 1388 |
|
|
2020
Q1 | $899K | Buy |
62,798
+5,700
| +10% | +$81.6K | ﹤0.01% | 1208 |
|
|
2019
Q4 | $1.56M | Buy |
+57,098
| New | +$1.56M | ﹤0.01% | 1165 |
|